Eligen B12™
Eligen B12™ is a once-daily oral non-prescription medical food, which normalises B12 levels without injection.
Imperial College London gets UK funding for Covid-19 vaccine
Since February, researchers at Imperial have been studying a self-amplifying RNA vaccine candidate in animals. Credit: © Imperial College London.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
Pilloxa
Pilloxa creates digital and remote solutions to optimise clinical trials...
About
Pilloxa creates digital and remote solutions to optimise clinical trials and patient support programmes through supporting medical adherence and patient retention.
FollowMake an Enquiry
-
Emisphere Technologies
Emisphere Technologies designs unique intracellular drug delivery mechanisms and advanced...
About
Emisphere Technologies designs unique intracellular drug delivery mechanisms and advanced oral formulations for pharmaceutical developers.
FollowMake an Enquiry
-
Noble Life Sciences
Noble Life Sciences is a contract research organisation (CRO) offering...
About
Noble Life Sciences is a contract research organisation (CRO) offering preclinical development solutions for drugs, vaccines and medical devices.
FollowMake an Enquiry